Vitamin D deficiency and musculoskeletal pain

سال انتشار: 1396
نوع سند: مقاله ژورنالی
زبان: انگلیسی
مشاهده: 370

متن کامل این مقاله منتشر نشده است و فقط به صورت چکیده یا چکیده مبسوط در پایگاه موجود می باشد.
توضیح: معمولا کلیه مقالاتی که کمتر از ۵ صفحه باشند در پایگاه سیویلیکا اصل مقاله (فول تکست) محسوب نمی شوند و فقط کاربران عضو بدون کسر اعتبار می توانند فایل آنها را دریافت نمایند.

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این مقاله:

شناسه ملی سند علمی:

JR_IJMPP-2-1_001

تاریخ نمایه سازی: 23 دی 1396

چکیده مقاله:

Vitamin D is one of the essential metabolic and physiological processes in the human body. Generally all people need 200-600 IU daily (Koutkia, Chen & Holick 2001). Production of vitamin D in the skin depends on some factors such as age, skin pigmentation and the amount of ultraviolet B (UVB)) available. The amount of UVB radiation is affected by geographic location, season, time and level of atmospheric pollution. The highest amount of vitamin D is provided to sunlight exposure (Gartner & Greer 2003) as well as obtaining from oily fish, fortified foods and supplement. The recommended vitaminD receiving depends on age, gender and deficiency treatment (Dobnig et al 2008). 1 Despite excessive oral vitamin D intake cause toxicity (Koutkia, Chen & Holick 2001), excessive sunlight exposure cannot cause vitamin D toxicity because UVB converts excess vitamin D3 to biologically inert isomers (Holick 2007). Different factors like physical inactivity, chronic acidosis, malnutrition, delayed puberty and malabsorption effect on bone mineralized (De Schepper 1990). Parathyroid hormone (PTH) compensate for reduced serum calcium with calcium absorption from the bones, causing bone deformities andthat this action has been done through activating osteoclasts inhabit. Excessive activate osteoclasts inhabit can lead to osteoporosis and increased PTH and serum calcium or metastatic calcification (Holick 2007). Severe vitamin D deficiency with corresponding elevations of PTH were reported in 88% of women who presented with muscle pains and weakness. Myalgia is generally the first manifestation of vitamin D deficiency(Glerup et al 2000). Vitamin D deficiency affects in all parts of the body (Gartner & Greer 2003). The high prevalence of vitamin D deficiency in patients with unspecified origin musculoskeletal pain was observed in the existed evidence (Gartner & Greer 2003). These studies represent there is significant relationship between unspecific pain and vitamin D deficiency that this relationship is independent of age group (Gartner & Greer 2003). There is a strong relationship between vitamin D deficiency and persistent non-specific musculoskeletal pain. Therefore, the patients who suffering from unknown origin pain may be required to control their serum levels of vitamin D consequent to vitamin D therapy (Mascarenhas & Mobarhan 2004). Studies have also shown that vitamin D therapy could improves extensive clinical complains regarding their bone pain and muscle weakness of women who referred to different clinics (Torrente de La Jara, Pecoud & Favrat 2004).

نویسندگان

Zahra Goli Rostami

Zibadasht Health Center, Alborz University of Medical sciences, Alborz, Iran.

Elaheh Dolatshahi

Faculty of medicine, Alborz University of Medical sciences, Alborz, Iran.